The phenomenon of 'chronic Lyme'; an observational study

European Journal of Neurology

Volumn 19, Issue 8, 2012, Pages 1128-1135

  Ljostad U ^a   Mygland, A ^a,b  

^a Sørlandet Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Bacterial infections; Post infectious syndromes

Indexed keywords

ANTIBODY;

ADULT; AGED; ANXIETY; ARTICLE; BORRELIA BURGDORFERI; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOCHONDRIASIS; LABORATORY TEST; LYME DISEASE; MALE; MINI MENTAL STATE EXAMINATION; OBSERVATIONAL STUDY; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; LYME DISEASE; MALE; MIDDLE AGED; QUALITY OF LIFE; YOUNG ADULT;

EID: 84863868588     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03691.x     Document Type: Article

References (30)

1. Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011; 17: 69-79.
2. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16.
3. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-1134.
4. Cameron D, Gaito A, Harris N, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2004; 2: 1-13.
5. Cameron DJ. Proof that chronic lyme disease exists. Interdiscip Perspect Infect Dis 2010; 2010: 876450.
6. Seidel MF, Domene AB, Vetter H. Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome. Eur J Clin Microbiol Infect Dis 2007; 26: 611-617.
7. Hsu VM, Patella SJ, Sigal LH. "Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 1993; 36: 1493-1500.
8. Hassett AL, Radvanski DC, Buyske S, et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008; 59: 1742-1749.
9. Djukic M, Schmidt-Samoa C, Nau R, Von SN, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis - the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic. Eur J Neurol 2011; 18: 547-555.
10. Feder HM Jr, Johnson BJ, O'Connell S, et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007; 357: 1422-1430.
11. Nygard K, Brantsaeter AB, Mehl R. Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Euro Surveill 2005; 10: 235-238.
12. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol 2006; 13: 1213-1215.
13. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993; 269: 2386-2391.
14. Ulvestad E, Kristoffersen EK. [False positive serological test in suspected borreliosis]. Tidsskr Nor Laegeforen 2002; 122: 88-90.
15. Schmidt C, Plate A, Angele B, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011; 76: 1051-1058.
16. Lerdal A, Wahl A, Rustoen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005; 33: 123-130.
17. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
18. Gerdes TT, Noyes R Jr, Kathol RG, et al. Physician recognition of hypochondriacal patients. Gen Hosp Psychiatry 1996; 18: 106-112.
19. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The revised Illness Perception Questionnaire (IPQ-R). Psychology and Health 2002; 17: 1-16.
20. Hammers-Berggren S, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol 1994; 32: 1519-1525.
21. Strle F, Ruzic-Sabljic E, Cimperman J, Lotric-Furlan S, Maraspin V. Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006; 43: 704-710.
22. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-1444.
23. Rupprecht TA, Elstner M, Weil S, Pfister HW. Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 2008; 37: 781-785.
24. Ljostad U, Mygland A. Remaining complaints 1year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol 2010; 17: 118-123.
25. Treib J, Grauer MT, Haass A, Langenbach J, Holzer G, Woessner R. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur Neurol 2000; 43: 107-109.
26. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-959.
27. Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005; 5: 46.
28. Statistics Norway. Survey of Living Conditions 2002, cross-sectional survey. Oslo: Statistics Norway, 2004.
29. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
30. Eikeland R, Mygland A, Herlofson K, Ljostad U. European neuroborreliosis: quality of life 30months after treatment. Acta Neurol Scand 2011; 124: 349-354.